During one study visit, patients were interviewed, examined clinically and assessed with FRDA rating scale (FARS) [7], including staging of global functioning, questions on
Ygland et al: Friedreich ataxia p.R165P point mutation 4
activities of daily living (ADL), neurological examination as well as the 9-hole peg test and the PATA speech test.